| Name | Title | Contact Details |
|---|
Aware Health is a B2B partner that delivers modern solutions to self-insured employers to contain orthopedic claims costs.
bodyevolutionorg is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Focused on improving the health of student populations, TimelyMD offers universities and colleges a comprehensive, custom program centered around telehealth. TimelyMD`s campus-wide solution gives students one point of contact--anytime, anywhere--to get quality care and immediate treatment for medical or mental health concerns from board certified physicians and licensed counselors. TimelyMD`s telehealth programs optimize clinic resources and support clinic staff in delivering quality care to the right students at the right times.
Forus Health is a medical technology start up founded in 2010 by a group of engineers with the goal to eradicate avoidable blindness. Over the years Forus Health has designed and developed affordable technology solutions to increase access and affordability of eye care. Our first product 3nethra classic is a compact and portable non-mydriatic fundus camera used for capturing digital images of the posterior (retina) and anterior (cornea) segments of the eye. The device is used for identifying common eye problems such as diabetic retinopathy, glaucoma, ARMD, cataract etc. The device is also integrated to a cloud based telemedicine platform which enables remote diagnosis. There are 40 million people who are blind globally, and 15 million live in India. The high incidence of blindness in India is due to a combination of several issues, but mostly due to limited access to eye care facilities, high cost of treatment/surgery and lack of awareness. The objective of Forus Health is to use technology to increase access, bring down the cost of diagnosis(affordability) and raise awareness (the three As). The key to our solution is not just the technology, but the way in which we have designed the deployment of the product.